{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:35:58Z","timestamp":1759412158679},"reference-count":58,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"William Langridge from the Juvenile Diabetes Foundation","award":["1-2000-812"],"award-info":[{"award-number":["1-2000-812"]}]},{"name":"National Institute of Diabetes and Digestive and Kidney Diseases section (NIDDK) of the National Institutes of Health","award":["DK-99-013"],"award-info":[{"award-number":["DK-99-013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.077","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T14:08:05Z","timestamp":1312380485000},"page":"8451-8458","source":"Crossref","is-referenced-by-count":24,"title":["Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function"],"prefix":"10.1016","volume":"29","author":[{"given":"Oludare","family":"Odumosu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dequina","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Langridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (21)","key":"10.1016\/j.vaccine.2011.07.077_bib0005","first-page":"1360","article-title":"Type I diabetes mellitus A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","article-title":"Insulin-dependent diabetes mellitus","volume":"85","author":"Tisch","year":"1996","journal-title":"Cell"},{"issue":"June (25)","key":"10.1016\/j.vaccine.2011.07.077_bib0015","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1161\/CIRCULATIONAHA.104.529651","article-title":"Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.96.3.1036","article-title":"Distinct dendritic cell subsets differentially regulate the class of immune response in vivo","volume":"96","author":"Pulendran","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.07.077_bib0025","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.167.9.5067","article-title":"Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo","volume":"167","author":"Pulendran","year":"2001","journal-title":"J Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(03)00175-4","article-title":"Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity","volume":"19","author":"Itano","year":"2003","journal-title":"Immunity"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.07.077_bib0035","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/2006","article-title":"Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions","volume":"4","author":"Piccinni","year":"1998","journal-title":"Nat Med"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2011.07.077_bib0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.mjt.0000178767.67857.63","article-title":"Autoimmune destruction of pancreatic beta cells","volume":"12","author":"Yoon","year":"2005","journal-title":"Am J Ther"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.07.077_bib0045","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/35095573","article-title":"Man the barrier! Strategic defences in the intestinal mucosa","volume":"1","author":"Nagler-Anderson","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)80106-3","article-title":"Epithelial M cells: gateways for mucosal infection and immunization","volume":"86","author":"Neutra","year":"1996","journal-title":"Cell"},{"issue":"February (5405)","key":"10.1016\/j.vaccine.2011.07.077_bib0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.283.5405.1183","article-title":"Reciprocal control of T helper cell and dendritic cell differentiation","volume":"283","author":"Rissoan","year":"1999","journal-title":"Science"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"issue":"April (1\u20132)","key":"10.1016\/j.vaccine.2011.07.077_bib0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-5728(01)00269-7","article-title":"Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance","volume":"115","author":"Liu","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"July (6)","key":"10.1016\/j.vaccine.2011.07.077_bib0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.lfs.2006.01.042","article-title":"Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation","volume":"79","author":"Li","year":"2006","journal-title":"Life Sci"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2011.07.077_bib0080","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1073\/pnas.88.22.10252","article-title":"Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin","volume":"88","author":"Zhang","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August","key":"10.1016\/j.vaccine.2011.07.077_bib0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","article-title":"Mucosal immunity and tolerance: relevance to vaccine development","volume":"170","author":"Czerkinsky","year":"1999","journal-title":"Immunol Rev"},{"issue":"30 (December)","key":"10.1016\/j.vaccine.2011.07.077_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1749-6632.1991.tb33454.x","article-title":"Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens","volume":"636","author":"Weiner","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"November (23)","key":"10.1016\/j.vaccine.2011.07.077_bib0095","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","article-title":"Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance","volume":"91","author":"Sun","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.07.077_bib0100","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","article-title":"Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit","volume":"93","author":"Sun","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/clim.2000.4927","article-title":"Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit","volume":"97","author":"Sun","year":"2000","journal-title":"Clin Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.077_bib0110","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/intimm\/12.10.1449","article-title":"Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression","volume":"12","author":"Sun","year":"2000","journal-title":"Int Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.07.077_bib0115","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0952-7915(02)00384-9","article-title":"Recent advances in mucosal vaccines and adjuvants","volume":"14","author":"Eriksson","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/IAI.71.1.504-509.2003","article-title":"Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches","volume":"71","author":"Shreedhar","year":"2003","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MB:32:1:001","article-title":"Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis","volume":"32","author":"Carter","year":"2006","journal-title":"Mol Biotechnol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.07.077_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.imbio.2010.09.008","article-title":"Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit","volume":"216","author":"Odumosu","year":"2011","journal-title":"Immunobiology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.cgt.7701109","article-title":"Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B","volume":"15","author":"Fensterle","year":"2008","journal-title":"Cancer Gene Ther"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vaccine.2007.10.060","article-title":"Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects","volume":"26","author":"Facciabene","year":"2007","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0145","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/diabetes.55.03.06.db05-1417","article-title":"Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes","volume":"55","author":"Devaraj","year":"2006","journal-title":"Diabetes"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2007-2185","article-title":"Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state","volume":"93","author":"Devaraj","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.07.077_bib0155","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.0800489","article-title":"IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow","volume":"182","author":"Parrish","year":"2009","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.077_bib0160","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1634\/stemcells.2007-0022","article-title":"Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro","volume":"25","author":"Potapova","year":"2007","journal-title":"Stem Cells"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.077_bib0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/02713680802190085","article-title":"Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay","volume":"33","author":"LaFrance","year":"2008","journal-title":"Curr Eye Res"},{"issue":"April (9)","key":"10.1016\/j.vaccine.2011.07.077_bib0170","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","article-title":"A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes","volume":"94","author":"Bergerot","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.077_bib0175","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0180","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/diab.47.2.186","article-title":"The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse","volume":"47","author":"Sobel","year":"1998","journal-title":"Diabetes"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2011.07.077_bib0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.cji.0000171315.82997.9a","article-title":"Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens","volume":"28","author":"Denes","year":"2005","journal-title":"J Immunother"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/MB:34:3:317","article-title":"Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses","volume":"34","author":"Denes","year":"2006","journal-title":"Mol Biotechnol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.077_bib0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/dia.2009.0116","article-title":"Autoantigens plus interleukin-10 suppress diabetes autoimmunity","volume":"12","author":"Denes","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0200","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-3083.2007.02054.x","article-title":"Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus","volume":"67","author":"Zorena","year":"2008","journal-title":"Scand J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.077_bib0205","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2174\/092986706776360879","article-title":"Targeting cytokines of the interleukin-12 family in autoimmunity","volume":"13","author":"Kang","year":"2006","journal-title":"Curr Med Chem"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.07.077_bib0215","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0220","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.077_bib0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.077_bib0230","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell Immunol"},{"issue":"March (9617)","key":"10.1016\/j.vaccine.2011.07.077_bib0240","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.07.077_bib0245","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"issue":"May (7090)","key":"10.1016\/j.vaccine.2011.07.077_bib0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"May (7090)","key":"10.1016\/j.vaccine.2011.07.077_bib0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.07.077_bib0260","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/IAI.69.9.5716-5725.2001","article-title":"Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells","volume":"69","author":"George-Chandy","year":"2001","journal-title":"Infect Immun"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0265","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1189\/jlb.1207850","article-title":"Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation","volume":"84","author":"D\u2019Ambrosio","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.077_bib0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1348-0421.2005.tb03632.x","article-title":"Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity","volume":"49","author":"Isomura","year":"2005","journal-title":"Microbiol Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.077_bib0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nbt0398-292","article-title":"Efficacy of a food plant-based oral cholera toxin B subunit vaccine","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2011.07.077_bib0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4615-4729-7_13","article-title":"Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization","volume":"464","author":"Arakawa","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.07.077_bib0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pep.2009.04.002","article-title":"Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli","volume":"66","author":"Gong","year":"2009","journal-title":"Protein Expr Purif"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.07.077_bib0290","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2006.10.039","article-title":"Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm","volume":"25","author":"Gong","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:20:36Z","timestamp":1543623636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":58,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011273"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}